Kyowa Kirin
Kyowa Kirin Co., Ltd., a prominent biopharmaceutical company, is headquartered in Tokyo, Japan (JP). Founded in 1949, the company has established a strong presence in the global healthcare industry, focusing on innovative drug development in areas such as oncology, nephrology, and immunology. Kyowa Kirin is renowned for its unique biologics and small molecule therapies, which leverage advanced technologies to address unmet medical needs. The company has achieved significant milestones, including the successful launch of several key products that have positioned it as a leader in the biopharmaceutical sector. With a commitment to research and development, Kyowa Kirin continues to expand its operational footprint across major regions, including North America, Europe, and Asia, solidifying its market position through strategic partnerships and a robust pipeline of therapeutic solutions.
DitchCarbon Score
How does Kyowa Kirin's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Kyowa Kirin's score of 31 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Kyowa Kirin's reported carbon emissions
In 2023, Kyowa Kirin reported total carbon emissions of approximately 82,944,000 kg CO2e globally, with emissions broken down into Scope 1 at about 23,536,000 kg CO2e, Scope 2 at approximately 16,382,000 kg CO2e, and Scope 3 at around 81,944,000 kg CO2e. This reflects a commitment to transparency in their emissions reporting, covering all relevant scopes. In Japan, the company’s emissions for 2023 were similar, with Scope 1 emissions at about 20,336,000 kg CO2e, Scope 2 at approximately 16,362,000 kg CO2e, and Scope 3 at around 81,944,000 kg CO2e. Kyowa Kirin has demonstrated a consistent approach to emissions management, although specific reduction targets or initiatives have not been disclosed. The absence of documented reduction targets suggests a need for further commitment to climate action within the industry context. Overall, the company’s emissions data indicates a focus on understanding and managing their carbon footprint, aligning with broader industry standards for sustainability and climate responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2010 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 706,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Kyowa Kirin is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
